It has been suggested that EZH2, acting as an epigenetic regulator, controls cell cycle and cell stemness and promotes epithelial–mesenchymal transition (EMT), metastatic progression in PCa and neuroendocrine transdifferentiation in CRPC [12,89,90]. This evidence concerns the gene EZH2 and posterior cortical atrophy.